Core Scientific, Inc. — Form 8-K Summary
Business Context and Reporting Period
Core Scientific, Inc. filed this Form 8-K on November 28, 2022, reporting an event occurring on November 21, 2022. The filing concerns a change in the company’s board composition and does not report operating or financial results for a measurement period.
Material Event
- Stacie Olivares resigned as a director of the Board and from all Board committees, effective November 21, 2022.
- The filing states that the resignation was not due to any disagreement with the Board, the company, or management regarding operations, policies, or practices.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, guidance, or other financial metrics.
Outlook, Risks, and Unusual Items
No new guidance, outlook, risk disclosures, contingencies, or unusual financial items are presented in the filing.
Facts Investors Should Verify
- The effective date and scope of Ms. Olivares’ resignation.
- Whether the Board appointed a replacement director or reconstituted any committees in subsequent filings.
- Any separate disclosures regarding the company’s financial condition, liquidity, debt obligations, or restructuring activities.